ArtNr |
TRC-B690025-100mg |
Hersteller |
Toronto Research Chemicals
|
CAS-Nr. |
18109-81-4 |
Menge |
100 mg |
Quantity options |
100 mg
10 mg
25 mg
50 mg
5 mg
|
Kategorie |
|
Typ |
Biochemicals |
Specific against |
other |
Purity |
>95% (HPLC) |
InCHI |
1S/C18H29NO3.C6H8O7/c1-4-17(16-10-8-7-9-11-16)18(20)22-15-14-21-13-12-19(5-2)6-3;7-3(8)1-6(13,5(11)12)2-4(9)10/h7-11,17H,4-6,12-15H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) |
Smiles |
CCC(C(=O)OCCOCCN(CC)CC)c1ccccc1.OC(=O)CC(O)(CC(=O)O)C(=O)O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Benzeneacetic acid, alpha-ethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Butyric acid, 2-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, citrate (1:1) (8CI), Ethanol, 2-[2-(diethylamino)ethoxy]-, 2-phenylbutyrate (ester), citrate (1:1) (8CI), 2-[2-(Diethylamino)ethoxy]ethyl-2-phenylbutyrate citrate (1:1), Abbott 36581, Acodeen, Butamirate citrate, Cough Cut, HH 197, Panatus, Sincodeen, Sincodin, Sincodix, Sinecod, Sinecond, Oxeladin impurity D, 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate, Oxeladin Hydrogen Citrate Impurity D as Citrate, Oxeladin Impurity D as Citrate |
Versandbedingung |
Raumtemperatur |
Gefahren-Info |
Shipping Info: Not a Dangerous good | Air Forbidden: False | Controlled Products: Not Controlled | Hazardous Class: Suspected of damaging fertility or the unborn child | UN #: UNNODG |
Lieferbar |
|
Manufacturer - Category |
API standards; Additional pharmaceutical toxicology reference materials |
Country of Origin |
Canada |
Shipping Temperature |
RT|Room Temperature |
Storage Conditions |
+4°C |
Molecular Weight |
499, 55 |
Shipping Info |
Not a Dangerous good |
Air Forbidden |
False |
Controlled Products |
Not Controlled |
MSDS Availability |
TRUE |
Hazardous Class |
Suspected of damaging fertility or the unborn child |
UN # |
UNNODG |
IUPAC |
2-[2-(diethylamino)ethoxy]ethyl 2-phenylbutanoate; 2-hydroxypropane-1, 2, 3-tricarboxylic acid |
Manufacturer - Synonym |
Benzeneacetic acid, alpha-ethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1, 2, 3-propanetricarboxylate (1:1), Butyric acid, 2-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, citrate (1:1) (8CI), Ethanol, 2-[2-(diethylamino)ethoxy]-, 2-phenylbutyrate (ester), citrate (1:1) (8CI), 2-[2-(Diethylamino)ethoxy]ethyl-2-phenylbutyrate citrate (1:1), Abbott 36581, Acodeen, Butamirate citrate, Cough Cut, HH 197, Panatus, Sincodeen, Sincodin, Sincodix, Sinecod, Sinecond, Oxeladin impurity D, 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate, Oxeladin Hydrogen Citrate Impurity D as Citrate, Oxeladin Impurity D as Citrate |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.